Several studies showed that post-EGFR pathways are involved in promoting cell migration, including the MEK/ERK1/2 pathway in colon cancer cells [13,14], or the PI3K/AKT signaling pathway in NSCLC [15]. This evidence concerns the gene MAP2K7 and non-small cell lung carcinoma.